This prospective cohort study was done in level 3 neonatal ICU over a period of 1 year  which included  neonates who received intravenous fluids for atleast 48 hours. Neonates who survived less than 48 h, chromosomal/  renal anomalies or had insufficient data were excluded. AKI was defined according to the modified  KDIGO criteria .Both AKI and non-AKI neonates were  followed till discharge. Incidence of AKI, mortality and morbidity outcomes were studied .Institutional ethical clearance was taken. Out of 750 neonates, 680 neonates were included and  66 (9.7 %) had AKI. Incidence of AKI varied occurring in 9.1% of  neonates born  at 22-29 weeks, 5% at 30-36 weeks and 15.6%  > 37 weeks .  593 (87.2 %) neonates were discharged and   87 ( 12.8%) had adverse outcome including DAMA and deaths  .Out of 87 , 37.8 %  had AKI  and   10.09 % had no  AKI . Neonates with AKI had longer hospital stay (16 days versus 10.15 days)   .Out of 66 AKI cases, 66.7%  had stage 1, 18.2%  had stage 2, 15.2% had stage 3. Median day of onset of AKI was 4  with interquartile range of (3-6). Total 56(84.8%) neonates had Early onset AKI i.e within 

Anupreet Tiwana has completed her MD Paediatrics at the age of 28 years from Dayanand Medical College Ludhiana under Baba Farid University of Health Sciences Faridkot ,Punjab. She has done Paediatric Critical care fellowship credited by Indian Academy of Paediatrics in 2024 from Dayanand Medical College and Hospital ,Ludhiana. Currently she is studying as Senior Resident in the department of Paediatrics at Dayanand Medical College Ludhiana